extraskeletal myxoid chondrosarcoma
GPTKB entity
Statements (38)
Predicate | Object |
---|---|
gptkbp:instanceOf |
rare soft tissue sarcoma
|
gptkbp:age |
adults
|
gptkbp:firstDescribed |
1953
Enzinger and Shiraki |
gptkbp:has5YearSurvivalRate |
60-70%
|
gptkbp:hasGeneticAlteration |
EWSR1-NR4A3 fusion
NR4A3 gene rearrangement |
gptkbp:hasImagingFinding |
myxoid signal on MRI
well-circumscribed mass |
gptkbp:hasImmunohistochemistryMarker |
gptkb:vimentin
S100 protein (variable) |
gptkbp:hasLocation |
soft tissues
|
gptkbp:hasMetastasisSite |
gptkb:cancer
gptkb:bone lymph nodes |
gptkbp:hasPeakIncidenceAge |
40-60 years
|
gptkbp:hasSexRatio |
male predominance
|
gptkbp:histology |
cords and strands of tumor cells
myxoid matrix |
https://www.w3.org/2000/01/rdf-schema#label |
extraskeletal myxoid chondrosarcoma
|
gptkbp:ICD-10_code |
C49.A
|
gptkbp:location |
trunk
limbs proximal extremities |
gptkbp:originatedIn |
mesenchymal cells
|
gptkbp:prevalence |
less than 3% of all soft tissue sarcomas
|
gptkbp:prognosis |
indolent course
risk of local recurrence risk of metastasis |
gptkbp:recurrence |
high
|
gptkbp:synonym |
gptkb:EMC
extraskeletal myxoid chondrosarcoma tumor |
gptkbp:treatment |
radiation therapy
chemotherapy surgical excision |
gptkbp:WHOClassification |
malignant soft tissue tumor
|
gptkbp:bfsParent |
gptkb:NR4A3
|
gptkbp:bfsLayer |
7
|